loading
Precedente Chiudi:
$13.66
Aprire:
$13.55
Volume 24 ore:
5,186
Relative Volume:
0.18
Capitalizzazione di mercato:
$27.53M
Reddito:
-
Utile/perdita netta:
$-4.85M
Rapporto P/E:
-43.13
EPS:
-0.31
Flusso di cassa netto:
$-3.95M
1 W Prestazione:
+1.83%
1M Prestazione:
-5.92%
6M Prestazione:
-18.91%
1 anno Prestazione:
-24.20%
Intervallo 1D:
Value
$13.45
$13.63
Intervallo di 1 settimana:
Value
$12.71
$13.75
Portata 52W:
Value
$8.74
$22.90

Cadrenal Therapeutics Inc Stock (CVKD) Company Profile

Name
Nome
Cadrenal Therapeutics Inc
Name
Telefono
904-300-0701
Name
Indirizzo
822 A1A NORTH, PONTE VEDRA
Name
Dipendente
4
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
CVKD's Discussions on Twitter

Confronta CVKD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CVKD
Cadrenal Therapeutics Inc
13.45 27.97M 0 -4.85M -3.95M -0.31
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
423.60 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.50 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
441.72 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.82 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
182.12 40.44B 447.02M -1.18B -868.57M -6.1812

Cadrenal Therapeutics Inc Stock (CVKD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-12-18 Iniziato Noble Capital Markets Outperform

Cadrenal Therapeutics Inc Borsa (CVKD) Ultime notizie

pulisher
03:25 AM

What the charts say about Cadrenal Therapeutics Inc. todayMarket Rally & Advanced Technical Signal Analysis - newser.com

03:25 AM
pulisher
01:39 AM

Is Cadrenal Therapeutics Inc. stock cheap compared to fundamentals2025 Market Overview & Verified Swing Trading Watchlists - newser.com

01:39 AM
pulisher
01:00 AM

Is Cadrenal Therapeutics Inc. trending in predictive chart modelsMarket Rally & Weekly Breakout Opportunity Watchlist - newser.com

01:00 AM
pulisher
12:08 PM

Price momentum metrics for Cadrenal Therapeutics Inc. explainedMarket Sentiment Report & Long-Term Safe Investment Plans - newser.com

12:08 PM
pulisher
Nov 02, 2025

What to do if you’re stuck in Cadrenal Therapeutics Inc.2025 Bull vs Bear & Smart Money Movement Tracker - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Applying Elliott Wave Theory to Cadrenal Therapeutics Inc.Trade Exit Summary & Verified Entry Point Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Quantitative breakdown of Cadrenal Therapeutics Inc. recent moveTrade Risk Summary & Safe Entry Momentum Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Measuring Cadrenal Therapeutics Inc.’s beta against major indicesQuarterly Trade Report & Reliable Momentum Entry Alerts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

What institutional flow reveals about Cadrenal Therapeutics Inc.Trend Reversal & Stepwise Swing Trade Plans - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Cadrenal Therapeutics Inc Stock Analysis and ForecastEarnings Beat Highlights & The Best Picks Hiding in Plain Sight - earlytimes.in

Nov 01, 2025
pulisher
Oct 31, 2025

Applying chart zones and confluence areas to Cadrenal Therapeutics Inc.Weekly Investment Recap & Fast Gain Stock Trading Tips - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Cadrenal Therapeutics Inc. stock a good choice for value investors2025 Volatility Report & Verified Entry Point Detection - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Kuick Research Releases Landmark Study On US Orphan Drug Rare Disease Market Highlighting Investment And Innovation Opportunities Through 2030 - Benzinga

Oct 31, 2025
pulisher
Oct 31, 2025

Combining machine learning predictions for Cadrenal Therapeutics Inc.July 2025 Weekly Recap & Accurate Buy Signal Notifications - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Viridian Therapeutics (NASDAQ:VRDN) Director Acquires $9,999,990.00 in Stock - Defense World

Oct 30, 2025
pulisher
Oct 29, 2025

Will Cadrenal Therapeutics Inc. see short term momentumQuarterly Earnings Summary & Long-Term Capital Growth Ideas - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Why Cadrenal Therapeutics Inc. stock is rated strong buy2025 Earnings Impact & Fast Moving Trade Plans - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Insider Sell: Matthew Szot Sells Shares of Cadrenal Therapeutics Inc (CVKD) - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Cadrenal Therapeutics Executives Sell Shares - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

CVKD CFO reports 3,600-share sale; 9,933 shares remain - Stock Titan

Oct 28, 2025
pulisher
Oct 28, 2025

CVKD insider Quang Pham reports sales under Rule 10b5‑1 plan - Stock Titan

Oct 28, 2025
pulisher
Oct 28, 2025

Can Cadrenal Therapeutics Inc. stock reach $100 price target2025 Trading Recap & Fast Entry Momentum Trade Alerts - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

History Review: Will Cadrenal Therapeutics Inc. stock outperform value stocksJuly 2025 Analyst Calls & Long-Term Capital Growth Ideas - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Aug Update: Can Cadrenal Therapeutics Inc. stock outperform in 2025 bull marketMarket Activity Summary & Weekly High Potential Stock Alerts - fcp.pa.gov.br

Oct 27, 2025

Cadrenal Therapeutics Inc Azioni (CVKD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.33
price down icon 0.21%
$92.90
price down icon 0.29%
$28.82
price up icon 0.74%
$104.39
price up icon 0.46%
biotechnology ONC
$312.52
price up icon 0.95%
$182.24
price down icon 3.63%
Capitalizzazione:     |  Volume (24 ore):